Stroke prevention in atrial fibrillation—An Asian stroke perspective

Hung‐Fat Tse(Queen Mary Hospital), Dayi Hu(Peking University People's Hospital), Andreas Clemens(Boehringer Ingelheim (Germany)), Rungroj Krittayaphong(Siriraj Hospital), Annette B. Pizarro-Borromeo(Philippine Heart Center), Mohammad Zubaid(Kuwait University), Chunxue Wang(Beijing Tian Tan Hospital), Amit Vora, Chern‐En Chiang(National Yang Ming Chiao Tung University), Paul Lim, Balbir Singh, Yong Jun Wang(Beijing Tian Tan Hospital), Moheeb Ahmed Ai-Abdullah(Prince Sultan University)
Heart Rhythm
March 15, 2013
10.1016/j.hrthm.2013.03.017
Cited by 153

Related Papers

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
|Journal of Arrhythmia|2017|193
Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese
|Nature Communications|2015|135
A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation.
|PubMed|2003|132
Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: A randomized placebo-controlled study
|American Heart Journal|2002|131
Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation
|Journal of the American College of Cardiology|2015|113